99mtc ethylene dicysteine scintigraphy for diagnosing cortical defects in acute pyelonephritis: a comparative study with 99mtc dimercaptosuccinic acid

Nuclear Medicine Communications

Volumn 25, Issue 9, 2004, Pages 967-970

  Atasever, Tamer ^a   Özkaya, Ozan ^a   Abamor, Evrim ^a   Söylemezoğlu, Oğuz ^a   Buyan, Necla ^a   Ünlü, Mustafa ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Acute pyelonephritis

Indexed keywords

ETHYLENE DERIVATIVE; ETHYLENE DICYSTEINE TC 99M; RADIOISOTOPE; SUCCIMER TC 99M; TECHNETIUM 99M; UNCLASSIFIED DRUG; CYSTEINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M ETHYLENEDICYSTEINE; TECHNETIUM TC 99M-ETHYLENEDICYSTEINE;

ACUTE PYELONEPHRITIS; ANALYTIC METHOD; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; KIDNEY FUNCTION; MALE; NEUROIMAGING; PRESCHOOL CHILD; QUANTITATIVE ANALYSIS; RADIODIAGNOSIS; RADIOSENSITIVITY; RATING SCALE; RENOGRAPHY; SCINTIGRAPHY; CHILD; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; HOSPITALIZATION; INFANT; KIDNEY CORTEX; KIDNEY FUNCTION TEST; KIDNEY PAPILLA NECROSIS; KIDNEY SCINTISCANNING; METHODOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

CHILD; CHILD, PRESCHOOL; CYSTEINE; FEMALE; HUMANS; INFANT; KIDNEY CORTEX; KIDNEY FUNCTION TESTS; KIDNEY PAPILLARY NECROSIS; MALE; ORGANOTECHNETIUM COMPOUNDS; RADIOISOTOPE RENOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID;

EID: 4444243698     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200409000-00016     Document Type: Article

References (23)

1. Jodal U, Lindberg U, Lincoln K. Level diagnosis of symptomatic urinary tract infection in childhood. Acta Paediatr Scand 1975; 64:201-208.
2. Rushton HG, Majd M. Dimercaptosuccinic acid renal scintigraphy for the evaluation of pyelonephritis and scarring: a review of experimental and clinical studies. J Urol 1992; 148:1726-1732.
3. Goldraich NP, Goldraich IH. Update on dimercaptosucccinic acid renal scanning in children with urinary tract infection. Pediatr Nephrol 1995; 9:221-226.
4. Gordon I. Indications for Tc-99舁m dimercaptosuccinic acid scan in children. J Urol 1987; 137:464-467.
5. Rosenberg AR, Rossleigh MA, Brydon MP, Bass SJ, Leighton DM, Farmsworth RH. Evaluation of acute urinary tract infection in children by dimercaptosucccinic acid scintigraphy: a prospective study. J Urol 1992; 148:1746-1749.
6. Jacobson B, Nolstedt L, Svenson L, Söderlundh S, Berg U. Tc-99舁m dimercaptosuccinic acid in the diagnosis of acute pyelonephritis: relation to clinical and radiological findings. Pediatr Nephrol 1992; 6:328-334.
7. Mandell GA. Economic issue in paediatric nuclear medicine: cortical scanning of acute pyelonephritis. Q J Nucl Med 1997; 1:302-308.
8. VanNerom CG, Bormans GM, De Roo MJ, Verbuggen AM. First experience in healthy volunteers with Tc-99舁m L, L-ethylenedicysteine, a new renal imaging agent. Eur J Nucl Med 1993; 20:738-746.
9. Gupta NK, Bomanji JP, Waddington W, Lui D, Costa DC, Verbuggen AM. Tc-99舁m L, L-ethylenedicysteine scintigraphy in patients with renal disorders. Eur J Nucl Med 1995; 22:617-624.
10. Kabasakal L, Turoðlu HT, Onsel C, Uslu I, Atay S, Cansýz T, et al. Clinical comparison of Tc-99舁m EC, Tc-99舁m MAG-3 and I-131 OIH. J Nucl Med 1995; 36:224-228.
11. Kabasakal L, Atay S, Vural VA, Ozker K, Sonmezoglu K, Demir M, et al. Evaluation of Tc-99舁m EC in renal disorders and determination extraction ratio. J Nucl Med 1995; 36:1398-1403.
12. Kabasakal L. Tc-99舁m ethylene dicysteine: a new renal tubular function agent. Eur J Nucl Med 2000; 27:351-357.
13. Piepsz A, Blaufox MD, Gordon I, Granerus G, Majd M, O'Reilly P, et al. Consensus of renal cortical scintigraphy in children with urinary tract infection. Semin Nucl Med 1999; 29:160-173.
14. Bland JK, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310.
15. Stokland E, Hellström M, Jacobson B, Jodal U. Renal damage one year after first urinary infection role of DMSA scintigraphy. J Pediatr 1996; 129:815-820.
16. Piepsz A, Pintelon H, Verboven M, Keuppens F, Jacobs A. Replacing Tc-99舁m DMSA for renal imaging. Nucl Med Commun 1992; 13:494-496.
17. Gordon I, Anderson PJ, Lythgoe MF, Orton M. Can Tc-99舁m MAG-3 replace Tc-99舁m DMSA in exclusion of a focal renal defect? J Nucl Med 1992; 33:2090-2093.
18. Bair HJ, Becker W, Schott G, Kuhn RH, Wolf F. Is there still a need for Tc-99 DMSA renal imaging? Clin Nucl Med 1995; 20:18-21.
19. Laguna R, Silva F, Orduna E, Conway JJ, Weiss S, Caldereon C. Tc-99舁m MAG-3 in early identification of pyelonephritis. J Nucl Med 1998; 39:1254-1257.
20. Sfakianakis GN, Georgiou MF. MAG-3 SPECT: a rapid procedure to evaluate the renal parenchyma. J Nucl Med 1997; 38:478-483.
21. Kibar M, Noyan A, Anarat A. Tc-99舁m EC scinitigraphy in children with various renal disorders: a comparative study with Tc-99舁m MAG-3. Nucl Med Commun 1997; 18:44-52.
22. Pruvulovich EM, Bomanji JB, Waddington WA, Rudrasingham P, Verbruggen A, Ell PJ. Clinical evaluation of Tc-99舁m EC in patients with chronic renal failure. J Nucl Med 1997; 38:809-814.
23. Kibar M, Yapar Z, Noyan A, Anarat A. Tc-99舁m EC and Tc-99舁m DMSA scintigraphy in the evaluation of renal parenchymal abnormalities in children. Ann Nucl Med 2003; 17:219-225.